What does increase (decrease) in reinsurance recoverable mean?

The net change in amounts expected to be recovered from reinsurers for claims paid or incurred by the company. This reflects the company's reliance on reinsurance partners to mitigate underwriting risk. Changes in this balance are monitored to assess the credit quality of reinsurance counterparties and the timing of claim settlements.

King Pharmaceuticals KG Increase (Decrease) in Reinsurance Recoverable

Increase (Decrease) in Reinsurance Recoverable at other companies

Everest GroupEG

$151M-39.1%

SiriusPointSPNT

-$82.1M-502%

Skyward Specialty Insurance Group, Inc.SKWD

$65.5M+0.2%

W.R. BerkleyWRB

-$15.25M-135%

Universal Insurance HoldingsUVE

-$98.67M-197%

Greenlight Capital RE, Ltd.GLRE

$4.85M+123%

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInReinsuranceRecoverable.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's increase (decrease) in reinsurance recoverable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's increase (decrease) in reinsurance recoverable?: King Pharmaceuticals (KG) reported increase (decrease) in reinsurance recoverable of -$2.65M in Q1 2026.
What does increase (decrease) in reinsurance recoverable mean?: The net change in amounts expected to be recovered from reinsurers for claims paid or incurred by the company. This reflects the company's reliance on reinsurance partners to mitigate underwriting risk. Changes in this balance are monitored to assess the credit quality of reinsurance counterparties and the timing of claim settlements.